Evidence map›Paper›PMID 27569372›Full record

ReviewExperimental eye research2016

Small leucine-rich repeat proteoglycans in corneal inflammation and wound healing.

Jihane Frikeche, George Maiti, Shukti Chakravarti

Open access · greenAbstract readReview
In one paragraph

Review in Experimental eye research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Paracrine regulations of IFN-γ secreting CD4Matrix biology : journal of the International Society for Matrix Biology · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Matrix lumican endocytosed by immune cells controls receptor ligand trafficking to promote TLR4 and restrict TLR9 in sepsis.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  14. Review
  15. Review
  16. Frontiers in molecular biosciences · 2021
    Article
  17. Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune Diseases.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2020
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jihane FrikecheDepartment of Medicine, Johns Hopkins School of Medicine, Baltimore, USA.
George MaitiDepartment of Medicine, Johns Hopkins School of Medicine, Baltimore, USA.
Shukti ChakravartiDepartment of Medicine, Johns Hopkins School of Medicine, Baltimore, USA; Department of Cell Biology, Johns Hopkins School of Medicine, Baltimore, USA; Department of Ophthalmology, Johns Hopkins School of Medicine, Baltimore, USA. Electronic address: schakra1@jhmi.edu.
Johns Hopkins Medicine · US

Funding

The Role of Lumican in the CorneaR01EY011654 · NEI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHAKRAVARTI, SHUKTI · 1997 to 2017
$6.1M
TGF beta and AKT signal-driven pathogenesis in keratoconusR01EY026104 · NEI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Shukti Chakravarti · 2016 to 2026
$4.2M
The Role of Lumican in the corneaR56EY011654 · NEI · JOHNS HOPKINS UNIVERSITY · PI CHAKRAVARTI, SHUKTI · 2007 to 2007
$474k
NEI NIH HHS R01 EY011654NEI NIH HHS R01 EY026104NEI NIH HHS R56 EY011654
6 · The paper itself

Abstract

The small leucine rich repeat proteoglycans are major components of the cornea. Lumican, keratocan, decorin, biglycan and osteoglycin are present throughout the adult corneal stroma, and fibromodulin in the peripheral limbal area. In the cornea literature these proteoglycan have been reviewed as structural, collagen fibril-regulating proteins of the cornea. However, these proteoglycans are members of the leucine-rich-repeat superfamily, and share structural similarities with pathogen recognition toll-like receptors. Emerging studies are showing that these have a range of interactions with cell surface receptors, chemokines, growth factors and pathogen associated molecular patterns and are able to regulate host immune response, inflammation and wound healing. This review discusses what is known about their innate immune-related role directly in the cornea, and studies outside the field that find interesting links with innate immune and wound healing responses that are likely to be relevant to the ocular surface. In addition, the review discusses phenotypes of mice with targeted deletion of proteoglycan genes and genetic variants associated with human pathologies.

Indexed as

AnimalsCorneaCorneal InjuriesHumansKeratitisSmall Leucine-Rich ProteoglycansWound HealingSmall Leucine-Rich ProteoglycansBiglycanCornea wound healingDecorinFibromodulinKeratocanLumicanOsteoglycinSLRPTLR

Identifiers

PMID27569372
PMCPMC5204247
OpenAlexW2511527634

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.